Variant report
Variant | rs460165 |
---|---|
Chromosome Location | chr3:161087710-161087711 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:24)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:24 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:161038392..161046344-chr3:161085640..161093564,25 | MCF-7 | breast: | |
2 | chr3:160934982..160947568-chr3:161079696..161093037,40 | MCF-7 | breast: | |
3 | chr3:160956184..160959035-chr3:161087488..161089202,2 | MCF-7 | breast: | |
4 | chr22:31475291..31477772-chr3:161087457..161089639,2 | MCF-7 | breast: | |
5 | chr10:3825671..3828241-chr3:161086476..161088870,2 | MCF-7 | breast: | |
6 | chr3:160999506..161001764-chr3:161085890..161088412,2 | MCF-7 | breast: | |
7 | chr3:160787784..160789478-chr3:161085891..161088171,2 | MCF-7 | breast: | |
8 | chr3:160936365..160960187-chr3:161078472..161094658,51 | MCF-7 | breast: | |
9 | chr3:161087613..161089123-chr3:161278946..161281684,2 | MCF-7 | breast: | |
10 | chr3:161086150..161088854-chr6:26156323..26158210,2 | MCF-7 | breast: | |
11 | chr3:160502508..160504789-chr3:161086438..161088676,2 | MCF-7 | breast: | |
12 | chr11:46622262..46624365-chr3:161085688..161088044,2 | MCF-7 | breast: | |
13 | chr17:57181517..57184200-chr3:161086879..161089854,2 | MCF-7 | breast: | |
14 | chr3:160813033..160824577-chr3:161083489..161092050,35 | MCF-7 | breast: | |
15 | chr3:160962510..160966697-chr3:161085167..161089151,3 | MCF-7 | breast: | |
16 | chr3:161087384..161090083-chr9:131900097..131902606,2 | MCF-7 | breast: | |
17 | chr20:45948103..45949754-chr3:161086879..161089062,2 | MCF-7 | breast: | |
18 | chr3:63914213..63915723-chr3:161085984..161088284,2 | MCF-7 | breast: | |
19 | chr16:89786488..89788334-chr3:161087418..161089454,2 | MCF-7 | breast: | |
20 | chr15:99190324..99192171-chr3:161086732..161088826,2 | MCF-7 | breast: | |
21 | chr16:83986674..83988846-chr3:161086778..161089338,2 | MCF-7 | breast: | |
22 | chr2:199451456..199452956-chr3:161085880..161088129,3 | MCF-7 | breast: | |
23 | chr12:12713891..12716367-chr3:161087265..161090021,2 | MCF-7 | breast: | |
24 | chr14:19019125..19019628-chr3:161087703..161088203,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000158805 | Chromatin interaction |
ENSG00000111266 | Chromatin interaction |
ENSG00000183963 | Chromatin interaction |
ENSG00000224738 | Chromatin interaction |
ENSG00000240138 | Chromatin interaction |
ENSG00000108395 | Chromatin interaction |
ENSG00000119383 | Chromatin interaction |
ENSG00000075399 | Chromatin interaction |
ENSG00000140961 | Chromatin interaction |
ENSG00000271052 | Chromatin interaction |
ENSG00000169251 | Chromatin interaction |
ENSG00000259424 | Chromatin interaction |
ENSG00000168298 | Chromatin interaction |
ENSG00000067082 | Chromatin interaction |
ENSG00000169255 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10804790 | 0.84[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1154701 | 0.81[AMR][1000 genomes] |
rs1382427 | 0.84[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1382428 | 0.83[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1478565 | 0.84[AMR][1000 genomes];0.90[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs1600209 | 0.84[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs163328 | 0.93[AFR][1000 genomes];0.95[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs189270 | 0.83[AMR][1000 genomes];0.91[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1993891 | 0.84[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs2404340 | 0.81[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs28515190 | 0.84[AMR][1000 genomes];0.89[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs336541 | 0.84[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336543 | 0.84[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336548 | 0.84[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336549 | 0.81[EUR][1000 genomes] |
rs336567 | 0.90[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336568 | 0.96[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs336569 | 0.84[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336570 | 0.91[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336572 | 0.82[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs336577 | 0.91[AMR][1000 genomes];0.93[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336579 | 0.95[AFR][1000 genomes];0.94[AMR][1000 genomes];0.94[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336580 | 0.96[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs336582 | 0.95[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs336583 | 0.91[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336585 | 0.90[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336586 | 0.90[AMR][1000 genomes];0.96[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336589 | 0.86[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336590 | 0.91[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336591 | 0.84[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs336593 | 0.86[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs339101 | 0.84[AMR][1000 genomes];0.93[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs3849524 | 0.82[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs4273380 | 0.83[EUR][1000 genomes] |
rs4350933 | 0.85[EUR][1000 genomes] |
rs4370045 | 0.82[EUR][1000 genomes] |
rs4493448 | 0.84[EUR][1000 genomes] |
rs455386 | 0.81[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs456611 | 0.90[AFR][1000 genomes];0.94[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs457272 | 0.83[AFR][1000 genomes];0.91[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs459515 | 0.96[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs459697 | 0.90[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4597724 | 0.85[EUR][1000 genomes] |
rs460508 | 0.90[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs461638 | 0.84[EUR][1000 genomes] |
rs462413 | 0.81[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs462514 | 0.96[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs463928 | 0.90[AFR][1000 genomes];0.99[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs464766 | 1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs465985 | 0.82[AMR][1000 genomes];0.85[EUR][1000 genomes] |
rs466399 | 0.90[AFR][1000 genomes];0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62279921 | 0.96[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs6441370 | 0.81[AMR][1000 genomes] |
rs6441371 | 0.81[AMR][1000 genomes] |
rs6441373 | 0.84[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs6762645 | 0.84[EUR][1000 genomes] |
rs6765269 | 0.84[EUR][1000 genomes] |
rs6775627 | 0.85[EUR][1000 genomes] |
rs6794601 | 0.83[EUR][1000 genomes] |
rs7611367 | 0.81[AMR][1000 genomes] |
rs7615592 | 0.86[EUR][1000 genomes] |
rs7623206 | 0.86[EUR][1000 genomes] |
rs7629987 | 0.82[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs7632797 | 0.81[AMR][1000 genomes] |
rs7638668 | 0.84[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs7647327 | 0.81[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs7653233 | 0.87[EUR][1000 genomes] |
rs7653361 | 0.82[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs9290073 | 0.82[EUR][1000 genomes] |
rs9290074 | 0.82[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs975323 | 0.84[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs9790314 | 0.88[EUR][1000 genomes] |
rs9821201 | 0.82[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs9846756 | 0.85[EUR][1000 genomes] |
rs9850455 | 0.88[EUR][1000 genomes] |
rs9863590 | 0.83[EUR][1000 genomes] |
rs9870059 | 0.82[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs9872514 | 0.90[EUR][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv931072 | chr3:160669567-161159779 | Enhancers Strong transcription Weak transcription Flanking Active TSS Active TSS Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 98 gene(s) | inside rSNPs | diseases |
2 | nsv533237 | chr3:161019834-161804660 | Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS ZNF genes & repeats Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 91 gene(s) | inside rSNPs | diseases |
3 | nsv829772 | chr3:161047817-161202554 | Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Strong transcription Weak transcription Flanking Bivalent TSS/Enh Active TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 88 gene(s) | inside rSNPs | diseases |
4 | nsv963570 | chr3:161076656-161088849 | Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription | Chromatin interactive regionlncRNA | 38 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:161059800-161089200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr3:161084400-161088400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr3:161084400-161088800 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
4 | chr3:161084600-161088200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
5 | chr3:161085400-161088200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr3:161085600-161088600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
7 | chr3:161085800-161088400 | Weak transcription | H9 Cell Line | embryonic stem cell |
8 | chr3:161086200-161088600 | Weak transcription | Stomach Mucosa | stomach |
9 | chr3:161087200-161087800 | Active TSS | Pancreatic Islets | Pancreatic Islet |
10 | chr3:161087400-161087800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr3:161087600-161087800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr3:161087600-161088600 | Weak transcription | H1 Cell Line | embryonic stem cell |
13 | chr3:161087600-161089200 | Bivalent/Poised TSS | Primary Natural Killer cells fromperipheralblood | blood |